首页> 外文期刊>American Family Physician >Reslizumab (Cinqair) for Eosinophilic Asthma

【24h】

Reslizumab (Cinqair) for Eosinophilic Asthma

机译：Reslizumab（Cinqair）用于嗜酸性嗜胞菌哮喘

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《American Family Physician》 |2017年第10期|共2页
作者
Bondar Anna; Carr Megan;
展开▼
作者单位

Cleveland Clin Cleveland OH 44106 USA;

UPMC St Margaret Pittsburgh PA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Reslizumab (Cinqair) for Eosinophilic Asthma [J] . Bondar Anna, Carr Megan American Family Physician . 2017,第10期

机译：Reslizumab（Cinqair）用于嗜酸性嗜胞菌哮喘
2. Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma [J] . Garry M Walsh Biologics: Targets and Therapy . 2013,第6期

机译：瑞舒单抗在嗜酸性粒细胞疾病中的概况及其在控制不良嗜酸性粒细胞性哮喘中的潜力
3. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma [J] . Allergy . 2020,第5期

机译：生物学（Benralizumab，Dupilumab，Mepolizumab，Omalizumab和Reslizumab）治疗的疗效和安全性对严重的嗜酸性哮喘。对EAACI指南的系统审查 - 关于在严重哮喘中使用生物学的建议
4. Eosinophilic Inflammation in Asthma [C] . M. Nagata Asia Pacific Congress of Allergology and Clinical Immunology . 2004

机译：哮喘中的嗜酸性炎症
5. The performance of the school nurses' asthma management behaviors in relationship to their asthma knowledge, asthma attitude and asthma self-efficacy . [D] . Quaranta, Judith Eve. 2013

机译：学校护士哮喘管理行为的表现与其哮喘知识，哮喘态度和哮喘自我效能的关系。
6. Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma [O] . Garry M Walsh 2013

机译：瑞舒单抗在嗜酸性粒细胞疾病中的概况及其在控制不良嗜酸性粒细胞性哮喘中的潜力
7. Real-World Evidence of Improved Patient Outcomes with Reslizumab in Adults with Severe Eosinophilic Asthma: A Subgroup Analysis of Patients Receiving Reslizumab for More Than 12 Months [O] . M. Wechsler, S.P. Peters, B.E. Chipps, 2020

机译：具有严重嗜酸性哮喘的成年人的患者结果改善患者结果的现实迹象：患者患者患者超过12个月的亚组分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号